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Abstract
Background: Chlamydial Inclusion membrane proteins (Incs), are involved in biochemical interactions
with host cells and infecting Chlamydiae. We have previously reported the role of two Chlamydia
trachomatis (CT) Incs, namely IncB and IncC in generating host immunity in CT infected women. Emerging
data shows involvement of Inc stimulated CD4 positive T cells in aiding host immunity in infected fertile
and infertile women through the secretion of interferon gamma. However the lack of data on the intra-
cytokine interplay to these Incs in infected cell milieu prompted us to investigate further.
Methods: A total of 14 CT-positive fertile, 18 CT-positive infertile women and 25 uninfected controls
were enrolled in this study. CD8 depleted, CD4 enriched cervical cells were isolated and upon stimulation
with IncB and IncC, modulation of cytokines (Interleukin (IL)-1 Beta, IL-4, IL-5, IL-6, IL-10, Interferon-
gamma, IL-12, IL-23, Tumor Necrosis Factor-alpha and Granulocyte macrophage colony-stimulating factor
(GM-CSF) and T cell lineage regulating transcription factors T-Bet and GATA3 was determined by real-
time reverse-transcriptase (RT)-PCR and ELISA.
Results: Significant higher expression (P < 0.05) of Interferon-gamma, IL-12, IL-23 and GM-CSF were
found in Inc-stimulated CD4 enriched cervical cells of CT-positive fertile women and contrastingly high IL-
1 Beta, IL-4, IL-5, IL-6 and IL-10 levels were found in CT-positive infertile women. Positive correlation (P
< 0.05) was found between Interferon-gamma and T-Bet levels in CT-positive fertile women and IL-4
mRNA and GATA3 levels in CT-positive infertile patients upon IncB and IncC stimulation.
Conclusion: Overall our data shows that CT IncB and IncC are able to upregulate expression of
cytokines, namely interferon-gamma, IL-12, IL-23 and GM-CSF in CT-positive fertile women while
expression of IL-1 Beta, IL-4, IL-5, IL-6 and IL-10 were upregulated in CT-positive infertile women. Our
study also suggests that Incs are able to modulate expression of T cell lineage determinants indicating their
involvement in regulation of immune cells.
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Background
Chlamydia trachomatis (CT) is an obligate intracellular
pathogen and is the leading cause of sexually transmitted
diseases (STD) globally [1] Chlamydial infection of the
lower genital tract ascends to the upper genital tract and
results in serious consequences to reproductive health,
such as infertility, ectopic pregnancy, and pelvic inflam-
matory disease (PID) [2]. In India, a high chlamydial
prevalence rate has been reported among symptomatic
women with or without fertility-related disorders [3-6].
CT infection and propagation within host genital epithe-
lial cells depends on a 48–72 hour unique biphasic devel-
opmental cycle, in which metabolically inert, infectious
elementary bodies (EBs) enter host cells, replicate by
binary division and differentiate into large reticulate bod-
ies (RBs) within a specialized vacuole called the inclusion
[7]. Chlamydial inclusion avoids fusing with components
of the lysosomal pathway, yet maintain the selective abil-
ity for acquiring resource-laden host vesicles from the exo-
cytic pathway, multivesicular bodies and lipid droplets. A
family of secreted proteins, termed Inclusion membrane
proteins (Incs), localized to the inclusion membrane
(IM), exert crucial roles in vesicle fusion events [8]. Incs
interact with host cell components and contribute to
inclusion maturation and chlamydial development [9].
IncA, IncB and IncC are proteins encoded by the first three
genes of Inc family respectively and are produced early in
the chlamydial life cycle [7]. Antibodies to IncA, IncB and
IncB have been detected in sera of infected animals and
humans [10-12]. Antigen specific MHC class I-restricted
CD8+ T cell responses have also been reported for mem-
brane associated incs [13-15].
Acquired immunity to chlamydial infection involves
humoral and cell-mediated immune responses in infected
individuals [16,17]. It is also reported that B cells and
CD4+ T cells are involved in providing immunity to CT
infection [18,19]. Further, adaptive immune protection to
CT involves recruitment of CD4+ or CD8+ T cells at sites of
infection in nonhuman primate models or by adoptive
transfer in mice models [20-25]. Furthermore, CD8+ T
cells play a minor protective role compared to that of
CD4+  T cells in genital chlamydial infection [20,26].
Cytokines produced by T cell subsets in response to CT
infection are known to influence each other through stim-
ulatory or inhibitory pathways and finally determine the
clinical course of infection by resulting in successful clear-
ance of CT or associated pathology [27]. Studies done in
our laboratory suggests that CT IncB and IncC generate
differential humoral and cell mediated immune
responses in CT infected fertile and infertile women [28].
It was further observed that invitro Inc stimulation of CD4
positive enriched T cells obtained from these patients
resulted in high levels of interferon gamma suggesting a
probable role of CD4 mediated T helper (TH 1) immune
protection. In this study we further investigated (i) expres-
sion of cytokines upon IncB and IncC stimulation of CD4
positive enriched T cells in CT positive fertile and infertile
women using cytokine specific RT-PCR and ELISA and (ii)
correlation of cytokines expression with TH cell differenti-
ation factors, namely T-Bet and GATA3.
Methods
Study population
A total of 35 symptomatic patients (having complaints of
cervical discharge, cervicitis and infertility), attending the
Gynaecology Outpatient Department of Safdarjung Hos-
pital, New Delhi, India from March 2008 to May 2008
were randomly enrolled for the study. Twenty five healthy
age-matched controls attending the family planning
department for birth control measures were also enrolled.
The study received approval from the hospital's ethics
review committee and prior informed written consent was
obtained from each patient. Procedures followed for sam-
ple collection were in accordance with the ethical stand-
ards for human experimentation established by the
Declaration of Helsinki of 1975 (revised in 1983). At
recruitment, a detailed clinical questionnaire was admin-
istered to each patient for collecting information on rea-
sons for referral, gynaecology history including
menstruation, symptoms of genital and urinary tract
infection, obstetric and medical histories. Patients with
positive urine pregnancy test, recent antibiotic therapy
and history of recently treated sexually transmitted infec-
tion and genital tuberculosis were excluded from the
study.
Fertile women were those having their last child birth
within the last 4 months to 1 year. Infertile women were
identified as those, which lack recognized conception
after 1.5 to 2 years of regular intercourse without the use
of contraception. The infertile group included women
with referred diagnostic laparoscopy [29].
Based on clinical history and diagnosis, the patients were
categorized into three groups. Group I comprised of CT-
uninfected healthy controls with no infertility problems,
Group II comprised of CT-positive fertile women and
Group III comprised of CT-positive infertile women.
Collection of samples
The vulva was examined for lesions and the cervix for
warts, ulcers, ectopy, erythma and discharge, if any. A cot-
ton tipped swab (Hi Media, Mumbai, India) was intro-
duced into the cervical canal through a Cusco's speculum
and after cleaning the endocervix with a cotton swab,
endocervical swabs were collected from patients for diag-
nosis of CT and other STD pathogens. For collection of
cervical cells, a cytobrush was placed within the endocer-Reproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
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vical canal so that the cells from the endocervical region
and the zone between the endocervical and ectocervical
regions (transformation zone) could be obtained. The
cytobrush was then transferred to a sterile centrifuge tube
containing sterile phosphate-buffered saline (PBS) (pH
7.2) supplemented with 100 U penicillin/ml, 100 μg
streptomycin/ml and 100 μg glutamine/ml. No samples
were collected from patients with friable cervix and con-
tact bleeding to ensure collection of cervical lymphocytes
only. Samples were then stored at 4°C, transported to the
laboratory and processed within 1 h.
Laboratory diagnosis
Endocervical samples were tested for chlamydial positiv-
ity by PCR analysis using CT specific 200 base pair (bp)
plasmid primers [30]. In addition, PCR detection of CT
incB (CT 232) and incC (CT 233) genes in all endocervical
samples was performed as mentioned earlier [31]. Diag-
nosis for other STD pathogens was done as described ear-
lier [29]. In brief, Neisseria gonorrhoeae,  Mycoplasma
hominis and Ureaplasma urealyticum were detected by cul-
ture while for diagnosis of Candida sp, bacterial vaginosis
and Trichomonas vaginalis microscopy was done on gram
stained smears.
Expression of CT IncB and IncC proteins
Recombinant clones containing full length gene
sequences of incB and incC cloned into pGEX expression
vectors (Amersham Pharmacia Biotech Inc., NJ, USA)
were obtained as a kind gift from Dr. Guangming Zhong
at Department of Microbiology and Immunology, Univer-
sity of Texas Health Science Center at San Antonio, USA.
These clones were further propagated in Terrific Broth
(Amresco, Ohio, USA) and production of glutathione S-
transferase (GST) fusion proteins was performed as
described elsewhere [32]. Upon purification, fusion pro-
teins were checked for consistency on sodium dodecyl sul-
phate (SDS)-polyacrylamide gels stained with a
Coomassie blue dye (Sigma-Aldrich) and frozen at -80°C
to be used in further assays.
Antibody assays
Cervical washes of patients and controls were assayed for
immunoglobulin G (IgG) antibodies to CT surface com-
ponents using a commercially available ELISA (Ridas-
creen, R-Biopharm AG, Darmstadt, Germany). Results
were obtained as mean absorbance of duplicated samples
at A450. An OD > 1.1 was considered positive.
CT IncB and IncC specific IgG2 titres in cervical washes
were determined by ELISA in 96-well plates coated with 1
μg antigen/well and 100 μL of cervical washes from
patients and controls as previously described [33]. Posi-
tive samples were defined as those yielding an absorbance
(OD) value at least two standard deviations (SDs) above
the mean value obtained from the panel of samples taken
from the negative subjects.
CT IncB and IncC specific IgG in cervical washes was fur-
ther determined by Western blot assay as described previ-
ously [28]. Patients who detected presence of a 38 kDa
band for IncB and a 44.4 kDa band for IncC were consid-
ered positive for western blot assay.
Purification and proliferation of CD4 positive T cells
Cervical cells were isolated and counted as described ear-
lier [34]. In brief, the tube containing the cytobrush was
vortexed before removing the brush and the cells were fil-
tered through a sterile 70-mm nylon cell strainer (Becton
Dickinson, San Diego, CA, USA) to make a homogeneous
preparation of cells. The population of the cell suspension
was pelleted down at 1,500 rpm for 10 min to yield cervi-
cal cells. The viability of cells was determined by a trypan
blue exclusion assay on a haemocytometer. CD8+T cells
were positively selected from cervical cells using CD8
MACS MicroBeads® (Miltenyi Biotec, CA, USA) according
to manufacturer's instructions. The magnetically labelled
CD8+ T cells were retained in the column while the unla-
belled cells which passed through the column were col-
lected. The purity of CD8 depleted, CD4+ T cells (collected
as flow through) was determined on a FACS Caliber (BD
Biosciences) using a PE-conjugated anti-CD4 monoclonal
antibody (Becton Dickinson, San Jose, USA) (See Addi-
tional file 1). This CD8-depleted cell fraction was used for
further assays and will be termed as CD4+ T cells.
The CD4+ T cells were further gently pelleted and sus-
pended in RPMI-1640 medium (Sigma-Aldrich) supple-
mented with 10% heat-inactivated human AB serum and
cultured in triplicate (2×105  cells/well) in round-bot-
tomed 96-well plates with or without stimulants in a total
volume of 200 μl. Subsequently cultures were incubated
in humidified 5% CO2 at 37°C for 12 h (for real-time RT-
PCR) and 72 h (for cell proliferation assays and cytokine
specific ELISA).
Stimulants
CT was grown on confluent McCoy cell monolayers at a
multiplicity of infection 2 (ratio of number of infection
forming units to the number of seeding cells was 2). Cells
were lysed and whole EBs (CT positive control) were puri-
fied as described previously [35]. The concentration of CT
Incs and other antigens was measured using Bradford
assay (Sigma-Aldrich, MO, USA) according to manufac-
turer's instructions. IncB (1 μg/ml) and IncC (1 μg/ml)
were used for all experiments. Phytohaemaglutinin (PHA
2 μg/ml) (Sigma-Aldrich) and free GST were used as pos-
itive control mitogen and negative control respectively in
each experiment. Optimum concentrations of antigens
and mitogen were determined in preliminary experimentsReproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
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as minimum concentrations giving maximal proliferation
at different time intervals post stimulation.
RNA extraction and real-time RT-PCR analysis for 
cytokines and transcription factors
Total RNA from IncB or IncC-stimulated CD4+ T cells was
isolated using RNeasyMini Kit (Qiagen, CA, USA), in
accordance with the manufacturer's instructions and
stored at -70°C. Complementary DNA (cDNA) was pre-
pared using a SuperScript™ First-Strand Reverse Tran-
scriptase kit (Invitrogen), in accordance with the
manufacturer's instructions. The cDNA solution was
diluted to 150 μl and stored at -20°C. All samples were
reverse transcribed in a single batch and were all analysed
for a given primer set in the same PCR run. The PCR
amplification employed reagents supplied in a DyNAmo™
SYBR® Green qPCR Kit (Finnzymes, Espoo, Finland), and
each reaction volume (20 μl total) contained 5 μl of
cDNA, and 0.5 μM of both primers. Sequences for endog-
enous control (β-actin) and cytokine genes (IL-1β, IL-4,
IL-5, IL-6, IL-10, IL-12, TNF-α, IFN-γ and GM-CSF) and
transcription factors (T-Bet and GATA3) used in this study
mentioned in Table 1 were same as earlier reported by Jas-
per et al.[36]. All primers were of HPLC-purified grade and
were commercially synthesized (MWG-Biotech AG, Eber-
sberg, Germany). The negative control included in each
reaction consisted of H2O substituted for cDNA. PCR
amplification was performed in an Applied Biosystems
7000 Real-Time PCR System (Applied Biosystems, CA,
USA) under universal cycling parameters for relative
quantification of cytokine expression in target samples
according to the manufacturer's instructions (Applied
Biosystems User Bulletin #2: Relative Quantitation of
Gene Expression). For data analysis, the 2-ΔΔCt method was
used to calculate fold change [37].
Quantification of secreted cytokines
Quantification of IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12, IFN-
γ, TNF-α, GM-CSF and IL-23 in culture supernatants of
IncB or IncC-stimulated CD4+ T cells was performed by
commercially available ELISA kits (eBiosciences, San
Diego, USA), in accordance with the manufacturer's
instructions. The minimum detectable cytokine concen-
trations for these assays as provided by the manufacturer,
were-IL-1β (4 pg/ml), IL-4 (2 pg/ml), IL-5 (4 pg/ml), IL-6
(2 pg/ml), IL-10 (2 pg/ml), IL-12 (4 pg/ml), IFN-γ (4 pg/
ml), TNF-α (4 pg/ml), GM-CSF (2.5 pg/ml) and IL-23 (15
pg/ml).
Statistical analysis
The Kruskal-Wallis non parametric test was used to com-
pare continuous variables among multiple groups. The
Mann-Whitney U test was used for comparing two groups.
Categorical variables were compared using χ2 test. The
results were presented with 95% confidence interval (CI)
and P < 0.05 was considered significant. All statistical
Table 1: Details of primers used in this study
No. Cytokine gene primers 5'-3' sequence
1 GM-CSF F* AGC CCT GGG AGC ATG TGA
GM-CSF R** GAG TAG AGA CAC TGC TGC TGA GAT G
2I L - β1F GCT GAT GGC CCT AAA CAG ATG
IL-β1R ACGAAT CTC CGA CCA CCA CTA
3I F N γ F GAA ACG AGA TGA CTT CGA AAA GCT
IFNγ R ATG TCC AAC GCA AAG CAA TAC A
4 IL-12 F TCG CGT TCA CAA GCT CAA GT
IL-12 R CA AAC CTG ACC CAC CCA AGA
5 TNF-α F GCC CGA CTA TCT CGA CTT TGC
TNF-α R A ACC TTC CCA AAC GCC TCC
6 IL4 F CCA CGG ACA CAA GTG CGA TAT
IL4 R CGT AAC AGA CAT CTT TGC TGC C
7 IL5 F AAA GGC AAA CGC AGA ACG TT
IL5 R CTC TTG GAG CTG CCT ACG TGT
8 IL6 F ACT CAC CTC TTC AGA ACG
IL6 R AGT AGT GAG GAA CAA GCC
9 IL10 F GGG AGA ACC TGA AGA CCC TCA
IL10 R AAC AAG AGC AAG GCC GTG G
10 T-Bet(TBX21) F AAC ACA GGA GCG CAC TGG AT
T-Bet(TBX21) R ATT GTG CTC CAG TCC CTC CA
11 GATA3 F AGA TGG CAC GGG ACA CTA CCT
GATA3 R ATT AAG CCC AAG CGA AGG C
12 B-actin F TGT GAT GGT GGG TAT GGG TC
B-actin R TAC AAT GAG CTG CGT GT
* Forward primer ** Reverse primerReproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
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analyses were performed with Graphpad Prism Version 5
(La Jolla, CA, USA).
Results
Study population
Laboratory diagnosis of CT
Cervical CT infection was diagnosed by CT specific 200 bp
plasmid PCR in 35 patients. Three of these patients were
found to be co-infected either with Candida sp., bacterial
vaginosis, T. vaginalis, M. hominis, U. urealyticum or N. gon-
orrhoeae in the cervix and were thus excluded from the
study. Based on clinical history and diagnosis, the patients
were categorized into three groups. Group I (GI, n = 25)
comprised of CT-uninfected healthy controls with no
infertility problems, Group II (GII, n = 14) comprised of
CT-positive fertile women and Group III (GIII, n = 18)
comprised of CT-positive infertile women. The median
ages of CT-positive infertile or fertile women and controls
were comparable (28, 26 and 27 years, respectively).
Detection of CT incB and incC
Detection of incB and incC in cervical samples was done
in all patients in group II (n = 14) and group III (n = 18)
which were positive for CT specific 200 bp plasmid PCR.
Using incB and incC PCRs, we detected positivity in group
II (86%, 86%) and group III (94%, 100%) respectively
(Table 2). Further, ELISA results showed that IgG2 anti-
bodies to both IncB and IncC were significantly more
prevalent in cervical washes of CT positive fertile and
infertile patients compared to controls (P < 0.05) (Table
2). Western blot assay showed significantly higher positiv-
ity in cervical washes of CT positive fertile and infertile
patients compared to controls (P < 0.05). Significantly
higher number of women positively detected IncB and
IncC IgG in CT positive fertile women as compared to CT-
positive infertile women (Table 2).
Cytokine mRNA expression levels in stimulated CD4+ T 
cells
mRNA for cytokines viz. IL-1β, IL-4, IL-5, IL-6, IL-10, IL-
12, TNF-α, IFN-γ and GM-CSF and transcription factors, T-
Bet and GATA3 was detected in stimulated CD4+ T cells in
all patients' groups. On stimulation of CD4+ T cells with
IncB or IncC, significant increase in mRNA expression lev-
els of IFN-γ, IL-12, GM-CSF (P < 0.05) was observed in
cells obtained from CT-positive fertile women compared
to controls and CT-positive infertile women. In contrast,
IL-1β, IL-4, IL-5, IL-6, IL-10 mRNA expression levels were
significantly higher (P < 0.05) in cells obtained from CT-
positive infertile women compared to controls and CT-
positive fertile women (Figure 1). On stimulation of CD4+
T cells with IncB or IncC, IFN-γ and T-Bet levels were
found to be positively correlated in CT-positive fertile
women (Figure 2) whereas IL-4 mRNA levels were posi-
tively correlated to GATA3 expression in CT-positive infer-
tile women (Figure 3).
ELISA for cytokines in cell supernatants of stimulated 
CD4+ T cells
Significantly higher levels of IL-1β, IL-6 and IL-10 were
secreted from IncB or IncC stimulated CD4+  T cells
obtained from CT-positive infertile women as compared
to CT-positive fertile women or controls (P < 0.05). In
contrast, IncB and IncC stimulated CD4+ T cells obtained
from CT-positive fertile women secreted significantly
higher levels of IL-12, IFN-γ, GM-CSF and IL-23 compared
to CT-positive infertile women or controls (P < 0.05). Sig-
nificantly high levels of TNF-α and IL-6 levels were
secreted in CD4+ T cells from CT-positive fertile and infer-
tile women compared to controls (Table 3). IL-4 and IL-5
were below detection limit in all culture supernatants
(data not shown). CD4+ T cells stimulated with free GST
showed no significant differences in levels of secreted
cytokines (data not shown).
Discussion
There is accumulating evidence on the role of CD4+ T cells
in providing vigorous protective immunity aiding clear-
ance of chlamydiae from host cells [21]. In this study, for
detection of CT infection in patients, we have used 200 bp
plasmid primers. Further the positivity for IncB and IncC
was evaluated in CT positive patients only. However, since
we have evaluated the IncB and IncC primers in limited
CT positive samples, further study on large sample size is
Table 2: Detection of C. trachomatis positivity in study population by PCR, ELISA and Western blot
ELISA PCR Western blot
CT IgG IncB IgG2 IncC IgG2 IncB IncC IncB IgG IncC IgG
GI (n = 25) 1 (4) 1(4) 2 (8) 0 (0) 0 (0) 1(4) 1(4)
GII (n = 14) 12 (86)a, m 10 (72)b, m 11 (79)c, m 12 (86)d, m 12 (86)e, m 9 (64)f, m 11 (79)g, m
GIII (n = 18) 9 (50)m 8 (44)m 7 (39)m 17 (94)m 18 (100)m 8 (44)m 7 (39)m
Note Table shows the number of patients who were positive for tests mentioned. Values in parenthesis denote percentage unless otherwise stated.
a P = 0.029 as compared to GIII; b P = 0.010 as compared to GIII; c P = 0.007 as compared to GIII;d P = NS as compared to GIII; e P = NS as 
compared to GIII; f P = 0.007 as compared to GIII, g P = 0.006 as compared to GIII; m P < 0.05 as compared to corresponding GI where,
Group I (GI) comprised of healthy women with no CT infection, Group II (GII) comprised of CT-positive fertile women, Group III (GIII) comprised 
of CT-positive infertile women. All categorical variables were compared using the χ2 test.Reproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
Page 6 of 13
(page number not for citation purposes)
required to assess whether these primers can be used for
detection of chlamydia infection. Antibodies to IncB and
IncC in cervical washes were significantly higher in CT-
positive fertile women compared to CT-positive infertile
women. These results were similar and statistically signif-
icant to a commercial kit used for detection of antibodies
to CT surface components. Antibodies are produced and
are present in the genital tract secretions following CT
infection, and the immunoprotective role of antibody-
mediated immunity has also been reported [12,18]. CT
IncA, B and C have been reported to be identified by their
reactivity to convalescent sera from experimentally
infected guinea pigs [10]. A major role for antibodies in
chlamydial immunity is the enhancement of Th1 cell acti-
vation via Fc receptor (FcR)-mediated processes involving
DCs. Moore et al. have reported that in vitro anti chlamy-
dial antibodies increase the rate of Th1 cell activation by
FcR+/+ but not FcR-/-antigen-presenting cells, providing a
mRNA expression of IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12, TNF-α, IFN-γ, GM-CSF, T-Bet and GATA3 in CD4+ cervical cells in GI,  GII and GIII after in vitro stimulation with IncB, IncC and CT EB Figure 1
mRNA expression of IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12, TNF-α, IFN-γ, GM-CSF, T-Bet and GATA3 in CD4+ 
cervical cells in GI, GII and GIII after in vitro stimulation with IncB, IncC and CT EB. Real-time RT-PCR analysis of 
mRNA levels was done at 12 hours post infection where, Group I (GI) comprised of healthy women with no CT infection, 
Group II (GII) comprised of CT-positive fertile women, Group III (GIII) comprised of CT-positive infertile women. * P < 0.05 
Expression of cytokine mRNA in GII compared to corresponding levels in GI and GIII by Kruskal Wallis test. Δ P < 0.05 
Expression of cytokine mRNA in GIII compared to corresponding levels in GI and GII by Kruskal Wallis test. All cytokines 
were normalised against corresponding levels of β-actin endogenous gene. The graph show results as fold change represented 
by bars. Bars represent mean ± s.e.m. for all experiments. X axis- Stimulants used in the study; Y-axis- Fold change in RNA 
expression under different conditions.
Scatter plot showing positive correlation between IFN-γ and T-Bet in (i) IncB and (ii) IncC stimulated cells from CT-positive  fertile women Figure 2
Scatter plot showing positive correlation between IFN-γ and T-Bet in (i) IncB and (ii) IncC stimulated cells 
from CT-positive fertile women.
(i) (ii)Reproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
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mechanistic basis for need of both T-cell and humoral
immune responses in protective immunity to chlamydial
reinfection [38,39].
Modulation of cytokines upon Inc-stimulation in CD4+ 
cervical cells from CT-positive infertile women
Major histocompatibility complex (MHC)-class II-
restricted CD4+ T cells play a central role both by respond-
ing to, or by orchestrating, the activation of other immune
components including cytokine production. In this study
we detected high levels of IL-1β, IL-6, IL-4, IL-5 and IL-10
in IncB or IncC-stimulated CD4+ T cells in CT-positive
infertile women compared to CT-positive fertile women
and controls. It has been reported that co-culture of CT
serovar L2 with human blood monocytes induced the
production of IL-1, a mediator of inflammation, tissue
remodelling, and scarring [40]. Further, it has been
reported that high levels of IL-1 have a toxic effect and
cause severe tissue damage in a human Fallopian tube
organ culture model following CT serovar D infection
[41]. High levels of IL-1β and TNF-α have also been
reported to be released from in vitro explant model upon
infection with CT serovar E [42,43]. These cytokines are
known to stimulate production of matrix metalloprotein-
ases leading to tubal scarring during CT infection [44,45].
In addition to IL-1, TNF-α, alone or along with IFN-γ and
GM-CSF are known to be involved in inducing IL-6 [46].
Although pleiotropic in nature, IL-6 is strongly correlated
with pathogenesis in chlamydial infection. Persistent
immune activation in the fallopian tube and elevated IL-
6 levels due to CT infection has been reported [47]. CD4+
T cells are considered the principle producers of IL-4 in an
immune response [48], although other cell types, like
mast cells, basophils, and CD4- T cells, can produce IL-4
as well [49,50]. IL-4 itself has been shown to be a domi-
nant factor for the induction of IL-4 expression in resting
T cells. Further, expression of IL-4 can be induced in Th
cells independent of IL-4 from non-Th cells [51,52]. In
young sexually active adolescent women diagnosed with
co-infection of oncogenic human papillomavirus and CT,
IL-4 transcripts correlating to IL-10 have been detected in
cervical samples [53]. Elevated levels of IL-4 and IL-5 in
splenic lymphocytes from IFN-γ--/--  mice following
chlamydia-specific challenge and the inability in control-
ling local chlamydial infection and associated tissue dam-
age and cellular infiltration has also been reported [54].
IL-10 is known to limit inflammatory and fibrotic damage
and might enhance chlamydial persistence [55]. In the
genital tract, elevated levels of IL-10 have been found in
infertile women with documented CT infections [29,56].
Kinjyo et al. have characterized IL-10 as a Th3/Tr1 regula-
tory cytokine, showing the over production of IL-10 and
TGF-β in the absence of a Th2 polarizing gene, SOC3, the
suppressor of cytokine signalling [57]. Faal et al., found
elevated levels of a T cell regulatory gene, forkhead box 3
(FOXP3), during active trachoma [58]. Additionally, Mark
et al., had demonstrated diminished FOXP3 and IL-10 lev-
els with early clearing of CT infection in a murine model
[59]. The antagonistic role of IL-10 towards production of
IFN-γ is also known. Yang et al., have reported that exces-
sive IL-10 production in BALB/c mice inhibits Th1-like
responses, including IFN-γ expression and the delayed-
type hypersensitivity response following chlamydial
infection, and consequently delays resolution of the infec-
tion [60]. Overall, these results indicate that IncB and
IncC might be involved in pathogenesis caused due to CT
infection in infertile women.
Modulation of cytokines upon Inc-stimulation in CD4+ 
cervical cells from CT-positive fertile women
We detected high levels of IL-12 and IL-23 in IncB or IncC-
stimulated CD4+ T cells from CT-positive fertile women
Scatter plot showing positive correlation between IL-4 and GATA3 in (i) IncB and (ii) IncC stimulated cells from CT-positive  infertile women Figure 3
Scatter plot showing positive correlation between IL-4 and GATA3 in (i) IncB and (ii) IncC stimulated cells 
from CT-positive infertile women.
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Table 3: Cytokine concentrations (pg/ml) in culture supernatants of stimulated cervical CD4+ T cells
GI GII GIII
IncB IncC EBs IncB IncC EBs IncB IncC EBs
IL-1β 141.8
(109.5–335.5)
169.3
(98.8–368.5)
243.6
(145.1–467.9)
312.3 
(109.8–489.2)
407.1
(135.2–444.2)
538.3
(124.8–767.3)
692.9a
(167–941.4)
825.3b
(182.8–982.3)
900c
(288.6–1231.3)
IL-6 146.7
(74.9–400.3)
159.4
(87.3–548.5)
299.92
(98.67–981.32)
604d
(132.2–871.6)
612.87e
(156.5–716.9)
751f
(187.97–1093.2)
900.63a
(441.4–1054.72)
878.41b
(422.9–1078.78)
1241.07c
(656.4–1878.3)
IL-10 278.4
(132.7–254.2)
287.9
(143.66–267.5)
313.7
(159.4–623.9)
500.3
(267.9–702)
587.1
(249.3–734.2)
643.9
(338.2–742.6)
1132.1a
(562.6–1441.9)
1278.3b
(600.3–1502.4)
1538.4c
(768.2–1709.07)
IL-12 187.6
(112.6–336.4)
193.6
(123.2–414.1)
265.9
(132.7–451.1)
345.9g
(231.4–552)
365.2h
(256.3–462.2)
463.2i
(259.7–606.3)
200.2
(168.4–378.4)
189.7
(179.3–334.8)
243
(182.1–356.2)
IFN-γ 443.6j
(125.1–600.8)
467.28k
(141–580)
580.3l
(154.2–671.4)
703.1g
(332.6–988.61)
571.3h
(311.9–814.3)
859.2i
(342.1–1460.5)
229.5
(110.1–300.8)
285.4
(154.2–412.6)
453.3
(189.5–432.9)
TNF-α 156.1
(72.5–254.3)
167.3
(73.2–269.1)
199.3
(82.2–343.5)
298.3d
(138.2–400)
271.9e
(128.3–438.6)
486.1f
(188.2–569.2)
248.6
(132.6–378.1)
263.2
(128.97–350.6)
411.2
(164.5–588.6)
GM-CSF 181.2
(85.8–243.7)
117.6
(93.6–229.7)
233.1
(106.4–259.9)
278.2g
(127.5–333.6)
282.5h
(148.3–313.4)
356.2i
(172.3–421.6)
172.4
(99.8–223.8)
186.7
(103.7–245.7)
228.9
(141.6–279.6)
IL-23 59.3
(43–176.5)
76.2
(57.2–217.4)
126.7
(105.6–211.3)
153.2g
(65.7–200.1)
134.7h
(87.2–213.2)
187.4i
(148.2–231)
75.2
(74.1–211)
88.6
(68.9–202.6)
147.5
(118.9–156)
Note. Data represents median values (bold). Values in parentheses depict range. All values in pg/ml unless otherwise stated. Along the horizontal axis are the stimulants IncB, IncC and EBs used in 
cells obtained from GI, GII and GIII and vertical axis are the cytokines secreted in cell cultures assayed using specific ELISAs.
a, b, c P < 0.05 Level of secreted cytokine in GIII compared to respective levels in groups I and II by Mann Whitney U test.
d, e, f P < 0.01 Level of secreted cytokine in GII compared to respective levels in group I by Mann Whitney U test.
g, h, i P < 0.05 Level of secreted cytokine in GII compared to respective levels in groups I and III by Mann Whitney U test.
j, k, l P < 0.05 Level of secreted cytokine in GI compared to respected levels in group III by Mann Whitney U test.Reproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
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compared to CT-positive infertile women and controls. IL-
12, which is derived from monocytes and dendritic cells
(DCs) is known to be important for the initial clearance
of bacteria [61-64] and for promoting IFN-γ production
by natural killer cells [65]. It has also been previously doc-
umented that clearance of chlamydial infection from
female adolescents has been associated with decrease in
IL-12 concentrations in endocervical samples [66]. We
have previously reported increased levels of IL-12 in cervi-
cal secretions of CT-positive infertile women compared to
cells in upper genital tract [29]. Further in another report,
a high percentage of plasmocytoid DCs in cervical secre-
tions of CT-positive infertile women [67] has suggested a
possible mechanism recognition of CD4 or CD8 antigens
on antigen presenting cells such as DCs. Phagocytosis of
chlamydiae induces DCs to produce IL-12, which in turn
promotes Th1 response and induces the presentation of
chlamydial antigens to CD4+ T-cells [68]. IL-23 is known
to activate macrophages to produce pro-inflammatory
cytokines and to improve antigen presentation by DCs
[69]. In addition, IL-23 has been described as acting indi-
rectly by inducing the production of Th1 polarizing
cytokines, such as IL-12 and IFN-γ in murine DCs [70]. It
has been reported that 60-kDa heat shock protein of C.
pneumoniae promotes a Th1 immune response through IL-
12/IL-23 production in monocyte-derived dendritic cells
[71]. Thus, IL-23 fosters the ability of IL-12 to polarize the
T cell response towards a Th1 pattern, which is protective
to intracellular pathogens, but can be detrimental if the
infection is not eradicated or if a re-infection occurs, lead-
ing to particularly strong activation of a Th1 response. Fur-
ther, it has also been reported that IL-23, plays a central
role in mediating chronic inflammatory responses and
autoimmunity in mice [72,73]. IL-23 is also a regulatory
factor that promotes IL-17-producing cells belonging to a
discrete T cell subset termed as Th17 and distinct from the
classical Th1 and Th2 cells [74,75]. Zhang et al., have
recently reported the antichlamydial effect of MyD88-
mediated IL-17 production which enhances inflamma-
tory cytokine production and neutrophil infiltration dur-
ing early stages of infection [76]. IL-17 is also known to
significantly increase progesterone secretion by JEG-3
choriocarcinoma cells [77]. Contrastingly, it has been
shown that CT serovar D infection in human trophoblast
cells alters cellular cholesterol biosynthesis, depletes pro-
gesterone synthesis and impairs trophoblast implantation
and placentation, thereby affecting pregnancy sequalae
[78]. In this study, Azenabor et al., used whole chlamydial
organisms and showed the mechanistic role of CT infec-
tion and the physiologic change meted on trophoblast.
However, since the differential effects of chlamydial anti-
gens on human reproduction is known [79], it is desirous
to conduct further investigations to know the effects of
Incs on host immunity through IL-17, a cytokine with sig-
nificant roles in both immune-mediated pathologies and
protection against microbial infections [80,81].
IncB or IncC-stimulated CD4+ T cells from CT-positive fer-
tile women produced IFN-γ and GM-CSF at levels higher
than in CT-positive infertile women and controls. CD4+
and CD8+ T cells are reported to be sources of IFN-γ pro-
duction in CT infection although the former is the major
contributor [82]. Further, the antichlamydial activity of
CD4+ T cells is primarily associated with the production of
high levels of IFN-γ [83-85]. IFN-γ reportedly promotes
the destruction of CT [86] but also triggers macrophage
release of inflammatory mediators that cause fibroblast
proliferation, thereby enhancing the synthesis of collagen.
In addition, IFN-γ delays the developmental cycle of CT so
that chlamydial reticulate bodies persist longer, which
might result in persistent unapparent infection and also,
play a role in immunopathogenesis by promoting inflam-
matory damage and fibrosis [87]. However in spite of the
dual functionality of IFN-γ, there is accumulated evidence
to suggest that Th1 responses and IFN-γ production are
important for optimal resolution of genital chlamydial
infection [1,19]. GM-CSF is known to activate macro-
phages and up-regulate CD14 and MHC class II expres-
sion resulting in more efficient antigen presentation and
development of protective immunity [88]. Further, in
these cells, IncB or IncC-stimulation produced TNF-α
higher than in controls. TNF-α along with IFN-α and IFN-
γ has been shown to synergistically enhance inhibition of
CT serovar D growth in vitro [89].
Modulation of transcription factors, T-Bet and GATA3 
upon Inc-stimulation
In this study we found elevated expression of transcrip-
tion factor T-Bet in Inc- stimulated CD4+ T cells from CT-
positive fertile and infertile women compared to controls.
Expression of T-Bet was found to be higher in cells of CT-
positive fertile women compared to CT-positive infertile
women. T-Bet has been identified as a Th1 cell-specific
factor that induces the production of IFN-γ by developing
Th2 cells. T-Bet is also reported to be involved in chroma-
tin remodelling of the gene that encodes IFN-γ, induction
of expression of the IL-12 receptor β2-subunit (IL-12Rβ2)
and stabilizing its own expression, either through an
intrinsic autocatalytic loop or the autocrine effects of IFN-
γ signalling [90]. Although both CD4+ and CD8+ T cells, as
well as NK cells express T-Bet, there is less dependence on
T-Bet for high-level expression of IFN-γ in CD8+ T cells
than in CD4+ T cells [91]. Further, the importance of T-Bet
for the development of Th1 responses in vivo is high-
lighted by the susceptibility of T-Bet knock-out mice to
challenge with Leishmania major and their predisposition
to allergic airway disease [92]. Thus higher expression of
T-Bet in CT-positive fertile women compared to CT-posi-
tive infertile women is indicative of differentiation ofReproductive Biology and Endocrinology 2009, 7:84 http://www.rbej.com/content/7/1/84
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native Th0 cells towards a CD4+-Th1 mediated protective
response for clearance of CT.
Elevated expression of GATA3 transcription factor was
detected in Inc stimulated CD4+ T cells from CT-positive
infertile women compared to CT-positive fertile women
and controls. GATA3 is a zinc-finger transcription factor
and is crucial for inducing key attributes of Th2 cells
including transcriptional competence of the Th2 cytokine
cluster, which includes the genes encoding IL-13, IL-4 and
IL-5 [93,94].
Overall, our data suggests that Th1 mediated immune
responses in CD4+ T cells can contribute to protection and
clearance of genital chlamydial infection. However, Th2
mediated responses can be detrimental and contribute
towards pathology of genital tracts and lead to long term
reproductive sequalae of CT infection in infected hosts.
In this study we investigated the role of CT IncB and IncC
specific immune responses in CD4+ cervical cells from
infected women by evaluating cytokine expression using
quantitative real time PCR and ELISA. These two methods
were selected as we were interested in studying expression
of cytokines at transcription and secretory levels. IL-4 and
IL-5 were detected only at the genomic level however their
levels were below detection limits in culture supernatants
by ELISA. It has been previously reported that the amount
of IL-4 secreted is not proportional at mRNA level [95].
Further, the subcellular localization, translation and
decay of cytokine transcripts and the overall post-tran-
scriptional control is critical in determining the amount of
IL-4 and IL-5 production in cells involved in immune
responses [96,97]. Although TNF-α mRNA transcripts
were detected, the levels in-between experimental groups
were of physiologically significance only in culture super-
natant secretions. It has been previously shown that TNF-
α expression is controlled at transcriptional and transla-
tional levels and is the basis for discrepancy between RT-
PCR and ELISA data [98,99]. Our study also indicates that
RT-PCR can be used for a relatively low number of cells
and could be efficient for simultaneous detection of mul-
tiple cytokines, especially those undergoing post-tran-
scriptional changes [100,101].
This study reiterates the importance of T-helper (Th)
responses in anti-chlamydial immunity with emphasis on
the contribution of CD4+ T cells. Our study is in contrast
with previous reports on MHC Class I restricted CD8+ T
cell recognition of Inc antigens derived from the cytosol
[13-15]. Nonetheless, as it has been well established that
both MHC Class I and II restricted pathways are involved
in presenting antigens to immunocompetent cells, the
simultaneous activation of both pathways by Inc antigens
can be explained. Incs localized to the IM are thought to
play important roles in exchanging both materials and
signals with host cells via the IM in order to establish and
maintain a successful intravacuolar growth [102-104].
Further, as human chlamydial vaccine research efforts are
underway to identify immunogenic proteins containing
adequate epitopes to elicit a vigorous Th1 and a sufficient
Th2 response, and antibody epitopes to induce a humoral
immune response required for optimal protection from
reinfection, the role of incs to this end are of interest.
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